240 related articles for article (PubMed ID: 28471096)
1. The emergence of new psychoactive substance (NPS) benzodiazepines: A review.
Manchester KR; Lomas EC; Waters L; Dempsey FC; Maskell PD
Drug Test Anal; 2018 Jan; 10(1):37-53. PubMed ID: 28471096
[TBL] [Abstract][Full Text] [Related]
2. Phantom menace: novel psychoactive substances and the UK Armed Forces.
Hunter AH; Ayres T; Moreland N; Cox A
J R Army Med Corps; 2018 Nov; 164(6):450-457. PubMed ID: 29934414
[TBL] [Abstract][Full Text] [Related]
3. An expanding world of new psychoactive substances-designer benzodiazepines.
Zawilska JB; Wojcieszak J
Neurotoxicology; 2019 Jul; 73():8-16. PubMed ID: 30802466
[TBL] [Abstract][Full Text] [Related]
4. New and Emerging Illicit Psychoactive Substances.
Graddy R; Buresh ME; Rastegar DA
Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
[TBL] [Abstract][Full Text] [Related]
5. Death cases involving certain new psychoactive substances: A review of the literature.
Kraemer M; Boehmer A; Madea B; Maas A
Forensic Sci Int; 2019 May; 298():186-267. PubMed ID: 30925344
[TBL] [Abstract][Full Text] [Related]
6. [Bonzai, lead and bath salt-poisoning with new and old drugs : Synthetic amphetamines, cathinones, cannabinoids and opioids-an overview].
Strube J; Schaper A
Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):684-692. PubMed ID: 29404633
[TBL] [Abstract][Full Text] [Related]
7. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
Gillet C; Polard E; Mauduit N; Allain H
Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
[TBL] [Abstract][Full Text] [Related]
8. Mortality related to novel psychoactive substances in Scotland, 2012: an exploratory study.
McAuley A; Hecht G; Barnsdale L; Thomson CS; Graham L; Priyadarshi S; Robertson JR
Int J Drug Policy; 2015 May; 26(5):461-7. PubMed ID: 25477285
[TBL] [Abstract][Full Text] [Related]
9. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.
Heikman P; Sundström M; Pelander A; Ojanperä I
Hum Psychopharmacol; 2016 Jan; 31(1):44-52. PubMed ID: 26763789
[TBL] [Abstract][Full Text] [Related]
10. [Can one talk of benzodiazepine "drunkenness"? About acute benzodiazepine intoxication, without suicidal or mortiferous tendencies].
Menecier P; Texier MA; Las R; Ploton L
Encephale; 2012 Feb; 38(1):25-30. PubMed ID: 22381720
[TBL] [Abstract][Full Text] [Related]
11. An investigation of the stability of emerging new psychoactive substances.
Soh YN; Elliott S
Drug Test Anal; 2014; 6(7-8):696-704. PubMed ID: 24573920
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of use and impairment from drugs and alcohol among trauma patients: A national prospective observational study.
Bråthen CC; Jørgenrud BM; Bogstrand ST; Gjerde H; Rosseland LA; Kristiansen T
Injury; 2023 Dec; 54(12):111160. PubMed ID: 37944451
[TBL] [Abstract][Full Text] [Related]
13. New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics.
Meyer MR
Arch Toxicol; 2016 Oct; 90(10):2421-44. PubMed ID: 27665567
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022.
Syrjanen R; Greene SL; Weber C; Smith JL; Hodgson SE; Abouchedid R; Gerostamoulos D; Maplesden J; Knott J; Hollerer H; Rotella JA; Graudins A; Schumann JL;
Int J Drug Policy; 2023 Dec; 122():104245. PubMed ID: 37944339
[TBL] [Abstract][Full Text] [Related]
15. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies.
Assi S; Gulyamova N; Ibrahim K; Kneller P; Osselton D
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631432
[TBL] [Abstract][Full Text] [Related]
16. Managing misuse of novel psychoactive substances.
Solomon D; Grewal P; Taylor C; Solomon B
Nurs Times; 2014 May 28-Jun 3; 110(22):12-5. PubMed ID: 24984370
[TBL] [Abstract][Full Text] [Related]
17. Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016.
Deen AA; Claridge H; Treble RD; Hamnett HJ; Copeland CS
J Psychopharmacol; 2021 Nov; 35(11):1315-1323. PubMed ID: 34182812
[TBL] [Abstract][Full Text] [Related]
18. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.
Rychert M; Wilkins C
Drug Test Anal; 2016 Aug; 8(8):768-78. PubMed ID: 26857892
[TBL] [Abstract][Full Text] [Related]
19. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project.
Beck O; Franzén L; Bäckberg M; Signell P; Helander A
Clin Toxicol (Phila); 2016 Aug; 54(7):568-75. PubMed ID: 27412885
[TBL] [Abstract][Full Text] [Related]
20. The potential utility of some legal highs in CNS disorders.
Davidson C; Schifano F
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():267-74. PubMed ID: 26232510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
